Month: January 2026

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO, OR INVITATION TO, ACQUIRE OR SUBSCRIBE FOR ANY SECURITIES IN KAROLINSKA DEVELOPMENT AB (PUBL) IN ANY JURISDICTION. PLEASE ALSO REFER TO THE SECTION “IMPORTANT INFORMATION” BELOW. Karolinska Development AB (publ) (”Karolinska Development” or the “Company”) announces that the Company has received additional guarantee commitments amounting to a total of approximately 20 MSEK in the Company’s ongoing rights issue of series B shares of approximately 202.6 MSEK before issue costs. The rights issue...

Aspo Plc  ANNOUNCEMENT  23.1.2026          Aspo Plc: Share repurchase 23.1.2026       In the Helsinki Stock Exchange         Trade date           23.1.2026  Bourse trade         Buy  Share                  ASPO  Amount             1 000 SharesAverage price/ share    7,5900 EURTotal cost            7 590,00 EUR          Aspo Plc now holds a total of 126 552 shares  including the shares repurchased on 23.1.2026       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5and the Commission Delegated Regulation (EU) 2016/1052.          On behalf of Aspo Plc         Nordea Bank Oyj              Sami Huttunen Ilari Isomäki       For more information, please contact:  Erkka Repo,...

LEI: 213800LRYA19A69SIT31 23 January 2026 HARGREAVE HALE AIM VCT PLC Publication of an Offer Document and Relevant Related Party Transaction Offer for Subscription Further to the announcement on 10 December 2025, the Board of Hargreave Hale AIM VCT plc (the “Company“) is pleased to announce that the Company has today published an offer document (the “Offer Document“) in relation to an offer for subscription under which the Company is seeking to raise up to £20 million together with the discretion to utilise an over-allotment facility to raise up to a further £10 million (the “Offer“). The Offer is now open and will close at 17.00 on 15 December 2026 (unless fully subscribed by an earlier date or closed at the Directors’ discretion). Persons intending to apply for ordinary shares under the Offer...

Paris, January 23, 2026  Half-year report on the liquidity contract signed between AIR France-KLM and Rothschild Martin Maurel Under the liquidity contract entrusted by Air France-KLM to Rothschild Martin Maurel, as of December 31, 2025, the following assets were held in the liquidity account: 0 Securities€9,942,376 During the period from August 1, 2025 to December 31, 2025, a total of:  Number of transactions performed Number of shares traded Transactions amounts in €Purchase 19,770 6,715,379 80,103,544.01Sale 23,921 6,715,379 79,962,657.33It should be noted that upon its implementation on August 1, 2025, the following assets were held in the liquidity account: 0 Securities€10,000,000 Relations Investisseurs                                                         Michiel Klinkers                        Marouane Mami                                        ...

January 23, 2026 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMFDate   Shares   Voting rightsTheoretical* Exercisable**31 December 2025 43,203,225 49,128,937 49,076,688*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights. **For information purposes, this number excludes the shares which voting rights have been suspended. The information is also available in the « Regulated Information » section of the Ipsos website: https://www.ipsos.com/en/regulated-informations/en....

PRESS RELEASECourbevoie – January 23, 2026 Bureau Veritas to acquire a leading Sustainability specialist for consumer products in Italy Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces the acquisition of SPIN360, a leading Italian consulting firm specialized in sustainable innovation and development across primary premium fashion and luxury brands.    This acquisition aligns with Bureau Veritas’ LEAP | 28 strategy to create new strongholds in the Consumer Product Services (CPS) industry, and to accelerate its growth in key markets such as Italy. The transaction will deliver on value creation opportunities, by combining SPIN360’s proprietary Life Cycle Assessment (LCA) tools and data-driven advisory services with Bureau Veritas’ certification and supply chain auditing expertise....

Stockholm, January 23, 2026 – Virtune AB (Publ) today announces an upcoming 10:1 share split of the Virtune Bitcoin Prime ETP (ticker: VIRBTCP). The share split will not affect the total value of investors’ holdings, and no action is required from investors. The share split is intended to facilitate trading in smaller denominations and thereby support improved trading liquidity and accessibility. Key information regarding the share split The share split will take effect at market open on February 2, 2026 in all markets where the product is available. Under the share split, each existing share of the Virtune Bitcoin Prime ETP will be split into ten (10) new shares. As a result, the NAV per share will be reduced by a factor of ten. The total value of each investor’s holding will remain unchanged, as the increase in the number of shares...

CEO Highlights Strategic Shift from Acquisition-Led Growth to Organic Expansion, Cost Discipline, and AI Infrastructure Initiatives to Drive Long-Term Value Celebration, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today announced preliminary unaudited revenue for fiscal year 2025, totaling an estimated $79 million. This represents an approximately 14% increase in revenue year-over-year, as compared to revenue for 2024 fiscal year. Joe La Rosa, CEO of La Rosa, commented, “In 2024, our growth strategy was largely acquisition-driven, as we focused on building scale and expanding our revenue base. In 2025, we deliberately shifted our focus toward organic growth, and we are particularly pleased that this year’s revenue increase was achieved...

RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has completed its acquisition of Astria Therapeutics, Inc., initially announced on October 14, 2025. The transaction strengthens its position as a leader in hereditary angioedema (HAE) and enhances the company’s long-term growth trajectory. BioCryst adds navenibart, a late-stage, long-acting plasma kallikrein inhibitor currently in Phase 3 clinical development, to its HAE portfolio. The potential to be the first HAE therapy with every-three and every-six month dosing, combined with a high level of attack control, positions navenibart to significantly improve the treatment experience for HAE patients. With the addition of navenibart, BioCryst could offer both the leading oral therapy (ORLADEYO®) and...